article thumbnail

CannaPacific and the University of Newcastle join forces to research cannabinoid pain treatment options

Cannabis Law Report

Australian biotechnology company CannaPacific and the University of Newcastle have announced a collaboration to advance the development of new cannabinoid-based pain treatments. … Read More.

article thumbnail

Cannabinoids and Glaucoma: Exploring the Science Behind Marijuana’s Effectiveness

LifeCannMD

In Florida, glaucoma is listed as a condition eligible for medical marijuana treatment. Cannabinoids and other compounds found in marijuana have been studied for their potential effects on glaucoma, a group of painful eye conditions that can lead to blindness. Besides lowering IOP, cannabinoids may also offer neuroprotective effects.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Science Behind Medical Marijuana: Exploring Cannabinoids and Their Therapeutic Effects

MMJ Recs

This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. We’ll explore the diverse range of cannabinoids and their health benefits, providing insights into how these compounds are revolutionizing healthcare.

article thumbnail

Medical Cannabis and Cancer Treatment: All You Need to Know

MMJ Recs

In recent years, the landscape of cancer treatment has witnessed a paradigm shift with the emergence of medical cannabis as a potential therapeutic ally. Today we’re here to explore the evolving relationship between medical cannabis and cancer treatment, shedding light on everything potential MMJ patients need to know.

article thumbnail

Is It Possible To Not Have Cannabinoid Receptors?

PrestoDoctor

The presence of cannabinoid receptors is well-documented and plays a crucial role in the body’s response to cannabinoids. While these receptors are crucial for regulating pain, immune function, and mood, the possibility of individuals lacking cannabinoid receptors altogether raises intriguing questions.

article thumbnail

Cannabinoids for Scleroderma

Project CBD

Two compounds that target the endocannabinoid system are currently in development to treat scleroderma – and they’re already in clinical trials. Pharmaceutical researchers have their sights set on developing a drug that bypasses CB1 while boosting CB2.

article thumbnail

Cannabinoids Could Limit Brain Injury Damage, Researchers Say

The Cannigma

Now, a research group at the Medical College of Georgia at Augusta University has been awarded a $1.8 Now, a research group at the Medical College of Georgia at Augusta University has been awarded a $1.8 Inhibition of MAGL using cannabinoids. The research at the focus of the new $1.8 Why, how, and when intervene?